ANDA Portfolio
Various (including Oncology)
Key Facts
About Quagen Pharmaceuticals
Quagen Pharma is a private, commercial-stage generic drug manufacturer with a fully integrated model encompassing development, regulatory submission, and manufacturing. The company operates from a 170,000 sq. ft. state-of-the-art facility and has demonstrated aggressive regulatory activity, submitting numerous Abbreviated New Drug Applications (ANDAs) to the FDA. Led by a seasoned management team with deep industry experience, Quagen targets a diverse product pipeline in oncology and other therapeutic areas, leveraging its capabilities in complex dosage forms like transdermal patches and controlled substances to compete in the generic market.
View full company profileAbout Belcher Pharmaceuticals
Belcher Pharmaceuticals is a private, commercial-stage company operating in the generic drug sector. It leverages its development and manufacturing capabilities for solid oral dosage forms to bring affordable generic products to market. With numerous ANDAs in development and a commitment to aggressive product introductions, Belcher aims to expand its offerings in the competitive generic pharmaceuticals space. The company's strategy centers on executing its R&D plans to grow its product portfolio for human and veterinary use.
View full company profile